15 Dec Predicting the clinical trials of the future: Top 4 trends to watch

By Laura Fernandes, PhD, Targeted Oncology

Clinical trials are continually pushing the envelope of what is possible with therapeutic interventions. These research partnerships are responsible for radically altering the way physicians have learned to treat cancers, rare diseases, and other conditions over the last several decades.

It’s no surprise that the way investigators conduct these trials is constantly evolving as well. The randomized clinical trial (RCT) remains the gold standard for establishing safety and effectiveness, but new trial designs are being developed as experts reintegrate lessons learned over time into the process of conducting reliable and reproducible research.

The advent of digital real-world data (RWD) and real-world evidence (RWE), as well as an explosion of advanced analytical tools, have revolutionized the way life sciences stakeholders interact with information and have made it possible to synthesize enormous volumes of data to generate deeper, and more actionable insights into patient experiences and outcomes.

As investigators become more adept at using RWD and RWE as a fundamental component of clinical trials, these resources have the potential to improve the way they enroll patients in research, conduct effective trials, follow patients over time, and ensure the safety and efficacy of new therapeutics.

Here are 4 top predictions for how clinical trials will evolve to better serve patients in 2023 and beyond. Read more …